Evidence map›Paper›PMID 41278179›Full record

ArticleJournal of arthropod-borne diseases2025

Exploring the Effectiveness of Chlorophacinone in Managing Urban Rat Infestation: A Laboratory Study on the Norway Rat,

Ariff Ateed Mohd-Noh, Yusdayati Rashid, Dzulhelmi Muhammad-Nasir, Cik Mohd Rizuan Zainal-Abidin

Abstract read
In one paragraph

Article in Journal of arthropod-borne diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ariff Ateed Mohd-NohCrop Protection and Biosolution Department, FGVRD Sdn Bhd, Tun Razak Agricultural Research Centre, Pahang Darul Makmur, Malaysia.
Yusdayati RashidCrop Protection and Biosolution Department, FGVRD Sdn Bhd, Tun Razak Agricultural Research Centre, Pahang Darul Makmur, Malaysia.
Dzulhelmi Muhammad-NasirCrop Protection and Biosolution Department, FGVRD Sdn Bhd, Tun Razak Agricultural Research Centre, Pahang Darul Makmur, Malaysia.
Cik Mohd Rizuan Zainal-AbidinCrop Protection and Biosolution Department, FGVRD Sdn Bhd, Tun Razak Agricultural Research Centre, Pahang Darul Makmur, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rat populations in urban areas must be monitored and controlled, as they can transmit zoonotic diseases and pose a risk to human health. Certain urban rat species may not respond well to some of the rodenticides available on the market. Therefore, this study aimed to assess the efficacy of chlorophacinone in controlling urban rats in a laboratory setting. Methods: Chlorophacinone, the primary focus of this study, was compared to a commonly used first-generation anticoagulant rodenticide (FGAR) available in the urban market, namely Coumatetralyl. Rat specimens were trapped in Kuantan, Pahang, and the dominant species was identified as Results: Overall, chlorophacinone demonstrated nearly complete mortality (95%) within an average of eight days post-feeding, followed by coumatetralyl, which exhibited high mortality (85%) within an average of seven days post-feeding. The rats in the chlorophacinone group consumed significantly lower dosages than those in the coumatetralyl group. This was due to variations in the default concentrations of the active ingredient of both treatments. Nevertheless, rats in the chlorophacinone treatment still experienced a higher mortality rate compared to coumatetralyl, despite consuming a lower dosage. Conclusion: Consequently, this finding suggests that

Indexed as

ChlorophacinoneFirst-generation anticoagulantRattus norvegicusRodenticide

Identifiers

PMID41278179
PMCPMC12630056

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.